TerminatedPhase 2NCT02591199
Engage 24: Evaluation of the Safety and Effectiveness of URG101 in Subjects With Interstitial Cystitis/Bladder Pain Syndrome
Studying Interstitial cystitis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Urigen
- Principal Investigator
- C. Lowell Parsons, MD, MSN NPUrigen
- Intervention
- URG101(drug)
- Enrollment
- 91 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2015 – 2018
Study locations (11)
- IC Study, LLC, Escondido, California, United States
- University of California San Diego, San Diego, California, United States
- Georgia Urology, Cartersville, Georgia, United States
- The Urogynecology Center, Overland Park, Kansas, United States
- Rutgers Women's Health Clinic, New Brunswick, New Jersey, United States
- The Arthur Smith Institue for Urology- North Shore Long Island Jewish Health System, Lake Success, New York, United States
- Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States
- MetroHealth System, Center for Advanced Gynecology, Cleveland, Ohio, United States
- Medical University of South Carolina, Charleston, South Carolina, United States
- Sanford Research, Sioux Falls, South Dakota, United States
- Urology of Virginia, PLLC, Virginia Beach, Virginia, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02591199 on ClinicalTrials.govOther trials for Interstitial cystitis
Additional recruiting or active studies for the same condition.
- ACTIVE NOT RECRUITINGPHASE2NCT06752603A Clinical Study of ONO-1110 in Patients With Hunner Type Interstitial CystitisOno Pharmaceutical Co. Ltd
- RECRUITINGEARLY PHASE1NCT04734106Safety and Efficacy of Aloe Vera in the Management of the Symptoms of Interstitial CystitisWake Forest University Health Sciences
- RECRUITINGNANCT06366269Acupuncture First for IC/BPSUniversity Hospitals Cleveland Medical Center
- RECRUITINGPHASE2NCT06394830Safety, Efficacy, and Frequency of Administration of VNX001 in the Treatment of Interstitial Cystitis / Bladder Pain Syndrome (IC/BPS)Vaneltix Pharma, Inc.
- RECRUITINGNCT06729151Effect of Intradetrusor onabotulinumtoxinA Injection Versus Conservative Management on Female Sexual Function in Patients With Bladder Pain SyndromeWalter Reed National Military Medical Center
- RECRUITINGNCT06719232Evaluating the Efficacy and Patient Experience of Catheter-Free Intravesical InstillationJahn Ferenc South Pest Teaching Hospital
- RECRUITINGPHASE2, PHASE3NCT06096597Amniotic Membrane Therapy for Interstitial Cystitis/Painful Bladder SyndromeDavid Sheyn
- RECRUITINGNANCT06299683Pain Type and Interstitial Cystitis/Bladder Pain Syndrome TreatmentVanderbilt University Medical Center